Correlation Between Pfizer and Daiichi Sankyo

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Daiichi Sankyo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Daiichi Sankyo into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Daiichi Sankyo, you can compare the effects of market volatilities on Pfizer and Daiichi Sankyo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Daiichi Sankyo. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Daiichi Sankyo.

Diversification Opportunities for Pfizer and Daiichi Sankyo

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Pfizer and Daiichi is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Daiichi Sankyo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daiichi Sankyo and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Daiichi Sankyo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daiichi Sankyo has no effect on the direction of Pfizer i.e., Pfizer and Daiichi Sankyo go up and down completely randomly.

Pair Corralation between Pfizer and Daiichi Sankyo

Considering the 90-day investment horizon Pfizer is expected to generate 2.8 times less return on investment than Daiichi Sankyo. But when comparing it to its historical volatility, Pfizer Inc is 4.97 times less risky than Daiichi Sankyo. It trades about 0.11 of its potential returns per unit of risk. Daiichi Sankyo is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  2,660  in Daiichi Sankyo on November 1, 2024 and sell it today you would earn a total of  106.00  from holding Daiichi Sankyo or generate 3.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.0%
ValuesDaily Returns

Pfizer Inc  vs.  Daiichi Sankyo

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Daiichi Sankyo 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Daiichi Sankyo has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Daiichi Sankyo is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pfizer and Daiichi Sankyo Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Daiichi Sankyo

The main advantage of trading using opposite Pfizer and Daiichi Sankyo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Daiichi Sankyo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daiichi Sankyo will offset losses from the drop in Daiichi Sankyo's long position.
The idea behind Pfizer Inc and Daiichi Sankyo pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency